Takuya Genda

Clinical practice guidelines for hepatocellular carcinoma: The Japan Society of Hepatology 2017 (4th JSH‐HCC guidelines) 2019 update

Norihiro Kokudo, Nobuyuki Takemura, Kiyoshi Hasegawa et al. · Hepatology Research · 2019 · 533 citations

Medicine, Oncology, Cancer Control +16

Ledipasvir and sofosbuvir fixed-dose combination with and without ribavirin for 12 weeks in treatment-naive and previously treated Japanese patients with genotype 1 hepatitis C: an open-label, randomised, phase 3 trial

Masashi Mizokami, Osamu Yokosuka, Tetsuo Takehara et al. · The Lancet Infectious Diseases · 2015 · 362 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +13

Clinical Practice Guidelines for Hepatocellular Carcinoma: The Japan Society of Hepatology 2021 version (5th JSH‐HCC Guidelines)

Kiyoshi Hasegawa, Nobuyuki Takemura, Tatsuya Yamashita et al. · Hepatology Research · 2023 · 269 citations · Full text

Medicine, Oncology, Pharmacotherapy +14

Sofosbuvir plus ribavirin in Japanese patients with chronic genotype 2 <scp>HCV</scp> infection: an open‐label, phase 3 trial

Masao Omata, Shuhei Nishiguchi, Yoshiyuki Ueno et al. · Journal of Viral Hepatitis · 2014 · 202 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Cell motility mediated by rho and rho-associated protein kinase plays a critical role in intrahepatic metastasis of human hepatocellular carcinoma

Takuya Genda, Michiie Sakamoto, Takafumi Ichida et al. · Hepatology · 1999 · 157 citations

Medicine, Cancer Biology, Oncology +17